Kommersiellt obunden läkemedelsinformation riktad till läkare och sjukvårdspersonal

Raloxifene

Classification: B

Drug products: Evista®, Raloxifen STADA, Raloxifene Teva

ATC code: G03XC01

Substances: raloxifene, raloxifene hydrochloride

Summary

As the substance is only used by women, analyses on sex or gender differences have not been considered relevant.

Additional information

Raloxifene is a selective estrogen receptor modulator (SERM). The approved indication for raloxifene is treatment of osteoporosis and osteoporosis prophylaxis in postmenopausal women [1,2].

Updated: 2016-12-23

Date of litterature search: 2016-12-20

References

Fass.se [cited 2016-12-20]. länk
Physicians' Desk Reference. http://www.pdr.net. [cited 2016-12-20]. länk
Läkemedelsstatistik. Stockholm: Socialstyrelsen. 2015 [cited 2016-12-19.] Socialstyrelsens statistikdatabas

Authors: Mia von Euler, Linnéa Karlsson Lind

Reviewed by: Mia von Euler

Approved by: Karin Schenck-Gustafsson